PCIB PCI Biotech Holding ASA

Flaggemelding

Flaggemelding

Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA.





EN
22/08/2025

Underlying

PCIBPCI Biotech Holding ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on PCI Biotech Holding ASA

 PRESS RELEASE
Free
PCIB PCI Biotech Hol...

Flaggemelding

Flaggemelding Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag solgt 2 000 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS ingen aksjer i PCI Biotech Holding ASA.

6h / 16m 1 EN
 PRESS RELEASE
Free
PCIB PCI Biotech Hol...

Flaggemelding

Flaggemelding Hawkeye Invest AS, et selskap som kontrolleres av Øystein Barmen, har i dag kjøpt 240 000 aksjer i PCI Biotech Holding ASA. Etter handelen eier Hawkeye Invest AS 2 000 000 aksjer, noe som utgjør 5,36% av aksjene i PCI Biotech Holding ASA.

9h / 23m 1 EN
 PRESS RELEASE
Free
PCIB PCI Biotech Hol...

PCI Biotech announces discontinuation of development of the PCL techno...

PCI Biotech announces discontinuation of development of the PCL technology and evaluation of future operations Oslo (Norway), 18 August 2025 – PCI Biotech Holding ASA (PCI Biotech, OSE:PCIB) today announces the discontinuation of development of the photochemical lysis (PCL) technology for viral vector manufacturing.  Today’s decision is primarily based on the insufficient progress towards the 2025 goal of demonstrating improved yield in mini benchtop bioreactors. Achieving successful end-to-end results in small bioreactors is a critical risk-reducing milestone for further development. Fol...

August 18, 2025 1 EN
 PRESS RELEASE
Free
PCIB PCI Biotech Hol...

PCI Biotech: Minutes of Annual General Meeting 2025

PCI Biotech: Minutes of Annual General Meeting 2025 Oslo, 22 May 2025. The Annual General Meeting in PCI Biotech Holding ASA took place today, 22 May 2025.  All the matters on the agenda were approved and the minutes of the Annual General Meeting are attached to this release and are available on Contact information:        PCI Biotech Holding ASA, Ullernchausséen 64, N-0379 Oslo        Ronny Skuggedal, CEO / CFO, , Mobile: This information is subject to a duty of disclosure pursuant to Section 5-12 of the Norwegian Securities Trading Act.  Attachment ...

May 22, 2025 1 EN
 PRESS RELEASE
Free
PCIB PCI Biotech Hol...

PCI BIotech: Disclosure of voting rights for Chair of the Board

PCI BIotech: Disclosure of voting rights for Chair of the Board Oslo, 20 May 2025. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of Hans Peter Bøhn, Chair of the Board of Directors. Hans Peter Bøhn is chair of PCI Biotech’s board of directors and shall open the annual general meeting of the Company on 22 May 2025. Mr. Bøhn holds 123,662 shares, representing 0.3 percent of the share capital of PCI Biotech. Mr. Bøhn has received powers of attorney to represent and vote for 3,957,330 additional shares. In total, Mr. Bøhn will represent and vote for...

May 20, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch